CN Creative raises £2 million in Series A

A UK start-up, CN Creative Ltd, which has developed an electronic smoking cessation device, has raised £2 million in a Series A round led by Advent Life Sciences. The money will support final development of its novel inhaler product.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom